The healthcare sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, hospitals, and health insurers. AI analysis examines pipeline progress, FDA approvals, revenue diversification, and profitability metrics from quarterly SEC filings.
Best Healthcare Stocks to Buy in 2026
Top-rated healthcare stocks ranked by AI confidence score. Dual AI analysis (Claude + ChatGPT) based on SEC 10-K and 10-Q filings. Last Updated: May 2026
CRMD
Confidence
90%
LLY
Confidence
86%
DXCM
Confidence
86%
CPRX
Confidence
86%
UFPT
Confidence
85%
ELTP
Confidence
84%
IDXX
Confidence
82%
KRYS
Confidence
82%
ADUS
Confidence
82%
UTHR
Confidence
82%
RSMDF
Confidence
82%
NBIX
Confidence
81%
All Healthcare Stocks (829)
| Ticker | Company | AI Rating | Confidence | Action |
|---|---|---|---|---|
| WLSS | Welsis Corp. | STRONG SELL | 98% | View Analysis → |
| SKVI | SKINVISIBLE, INC. | STRONG SELL | 98% | View Analysis → |
| SIGY | Sigyn Therapeutics, Inc. | STRONG SELL | 98% | View Analysis → |
| PIIIW | P3 Health Partners Inc. | STRONG SELL | 98% | View Analysis → |
| FCHS | First Choice Healthcare Solutions, Inc. | STRONG SELL | 98% | View Analysis → |
| SKYE | Skye Bioscience, Inc. | STRONG SELL | 97% | View Analysis → |
| QNCX | Quince Therapeutics, Inc. | STRONG SELL | 97% | View Analysis → |
| QCLS | Q/C TECHNOLOGIES, INC. | STRONG SELL | 97% | View Analysis → |
| PRPH | ProPhase Labs, Inc. | STRONG SELL | 97% | View Analysis → |
| SVRA | Savara Inc | STRONG SELL | 96% | View Analysis → |
| NIMU | NON INVASIVE MONITORING SYSTEMS INC /FL/ | STRONG SELL | 96% | View Analysis → |
| KAYS | Kaya Holdings, Inc. | STRONG SELL | 96% | View Analysis → |
| RGPX | REGENEREX PHARMA, INC. | STRONG SELL | 96% | View Analysis → |
| LUDG | LUDWIG ENTERPRISES, INC. | STRONG SELL | 96% | View Analysis → |
| IRME | IR-Med, Inc. | STRONG SELL | 96% | View Analysis → |
| GCAN | Greater Cannabis Company, Inc. | STRONG SELL | 96% | View Analysis → |
| ENDV | ENDONOVO THERAPEUTICS, INC. | STRONG SELL | 96% | View Analysis → |
| EMMA | Emmaus Life Sciences, Inc. | STRONG SELL | 96% | View Analysis → |
| EDGM | Edgemode, Inc. | STRONG SELL | 96% | View Analysis → |
| CPMD | CANNAPHARMARX, INC. | STRONG SELL | 96% | View Analysis → |
| CPHI | CHINA PHARMA HOLDINGS, INC. | STRONG SELL | 96% | View Analysis → |
| CLSDQ | Clearside Biomedical, Inc. | STRONG SELL | 96% | View Analysis → |
| CLCS | Cell Source, Inc. | STRONG SELL | 96% | View Analysis → |
| CELUW | Celularity Inc | STRONG SELL | 96% | View Analysis → |
| CDIOW | Cardio Diagnostics Holdings, Inc. | STRONG SELL | 96% | View Analysis → |
| ZVSA | ZyVersa Therapeutics, Inc. | STRONG SELL | 95% | View Analysis → |
| ZIVOW | Zivo Bioscience, Inc. | STRONG SELL | 95% | View Analysis → |
| YBGJ | Yubo International Biotech Ltd | STRONG SELL | 95% | View Analysis → |
| XAIR | Beyond Air, Inc. | STRONG SELL | 95% | View Analysis → |
| WHWK | Whitehawk Therapeutics, Inc. | STRONG SELL | 95% | View Analysis → |
| VVOS | Vivos Therapeutics, Inc. | STRONG SELL | 95% | View Analysis → |
| VTAK | Catheter Precision, Inc. | STRONG SELL | 95% | View Analysis → |
| VNRX | VOLITIONRX LTD | STRONG SELL | 95% | View Analysis → |
| VNDA | Vanda Pharmaceuticals Inc. | STRONG SELL | 95% | View Analysis → |
| VICP | Vicapsys Life Sciences, Inc. | STRONG SELL | 95% | View Analysis → |
| VERO | Venus Concept Inc. | STRONG SELL | 95% | View Analysis → |
| VCNX | VACCINEX, INC. | STRONG SELL | 95% | View Analysis → |
| UNCY | Unicycive Therapeutics, Inc. | STRONG SELL | 95% | View Analysis → |
| TVGNW | Tevogen Bio Holdings Inc. | STRONG SELL | 95% | View Analysis → |
| TIL | Instil Bio, Inc. | STRONG SELL | 95% | View Analysis → |
| TCRT | Alaunos Therapeutics, Inc. | STRONG SELL | 95% | View Analysis → |
| STSSW | Sharps Technology Inc. | STRONG SELL | 95% | View Analysis → |
| STME | Stimcell Energetics Inc. | STRONG SELL | 95% | View Analysis → |
| SNOA | Sonoma Pharmaceuticals, Inc. | STRONG SELL | 95% | View Analysis → |
| SMNRW | Semnur Pharmaceuticals, Inc. | STRONG SELL | 95% | View Analysis → |
| SLNCF | Silence Therapeutics plc | STRONG SELL | 95% | View Analysis → |
| SILO | Silo Pharma, Inc. | STRONG SELL | 95% | View Analysis → |
| SGP | SpyGlass Pharma, Inc. | STRONG SELL | 95% | View Analysis → |
| SERA | SERA PROGNOSTICS, INC. | STRONG SELL | 95% | View Analysis → |
| SCLXW | Scilex Holding Co | STRONG SELL | 95% | View Analysis → |
| RVP | RETRACTABLE TECHNOLOGIES INC | STRONG SELL | 95% | View Analysis → |
| RTGN | RetinalGenix Technologies Inc. | STRONG SELL | 95% | View Analysis → |
| RTEZ | REST EZ Inc. | STRONG SELL | 95% | View Analysis → |
| OTLC | Oncotelic Therapeutics, Inc. | STRONG SELL | 95% | View Analysis → |
| PVCT | PROVECTUS BIOPHARMACEUTICALS, INC. | STRONG SELL | 95% | View Analysis → |
| PTN | PALATIN TECHNOLOGIES INC | STRONG SELL | 95% | View Analysis → |
| PSTV | PLUS THERAPEUTICS, INC. | STRONG SELL | 95% | View Analysis → |
| PREM | Premier Air Charter Holdings Inc. | STRONG SELL | 95% | View Analysis → |
| PPCB | Propanc Biopharma, Inc. | STRONG SELL | 95% | View Analysis → |
| POSC | POSITRON CORP | STRONG SELL | 95% | View Analysis → |
| PMN | ProMIS Neurosciences Inc. | STRONG SELL | 95% | View Analysis → |
| PMI | Picard Medical, Inc. | STRONG SELL | 95% | View Analysis → |
| PLUR | Pluri Inc. | STRONG SELL | 95% | View Analysis → |
| PKTX | ProtoKinetix, Inc. | STRONG SELL | 95% | View Analysis → |
| PCSC | Perceptive Capital Solutions Corp | STRONG SELL | 95% | View Analysis → |
| PAVM | PAVmed Inc. | STRONG SELL | 95% | View Analysis → |
| NIKA | NIKA PHARMACEUTICALS, INC | STRONG SELL | 95% | View Analysis → |
| MDCXW | Medicus Pharma Ltd. | STRONG SELL | 95% | View Analysis → |
| MCUJF | MEDICURE INC | STRONG SELL | 95% | View Analysis → |
| MCLE | Medicale Corp. | STRONG SELL | 95% | View Analysis → |
| ISPC | iSpecimen Inc. | STRONG SELL | 95% | View Analysis → |
| MRAI | Marpai, Inc. | STRONG SELL | 94% | View Analysis → |
| MGRX | MANGOCEUTICALS, INC. | STRONG SELL | 94% | View Analysis → |
| MCAGU | Mountain Crest Acquisition Corp. V | STRONG SELL | 94% | View Analysis → |
| MAIA | MAIA Biotechnology, Inc. | STRONG SELL | 94% | View Analysis → |
| LYRA | Lyra Therapeutics, Inc. | STRONG SELL | 94% | View Analysis → |
| JAGX | Jaguar Health, Inc. | STRONG SELL | 94% | View Analysis → |
| IVF | INVO Fertility, Inc. | STRONG SELL | 94% | View Analysis → |
| ITRM | Iterum Therapeutics plc | STRONG SELL | 94% | View Analysis → |
| GELS | Gelteq Ltd | SELL | 94% | View Analysis → |
| GALT | GALECTIN THERAPEUTICS INC | STRONG SELL | 94% | View Analysis → |
| ERNAW | Ernexa Therapeutics Inc. | STRONG SELL | 94% | View Analysis → |
| ENVB | Enveric Biosciences, Inc. | STRONG SELL | 94% | View Analysis → |
| ENSCW | Ensysce Biosciences, Inc. | STRONG SELL | 94% | View Analysis → |
| EMED | Electromedical Technologies, Inc | STRONG SELL | 94% | View Analysis → |
| EBRCZ | EBR Systems, Inc. | STRONG SELL | 94% | View Analysis → |
| CYTOF | Altamira Therapeutics Ltd. | SELL | 94% | View Analysis → |
| CYDY | CytoDyn Inc. | STRONG SELL | 94% | View Analysis → |
| CTRVP | Hepion Pharmaceuticals, Inc. | STRONG SELL | 94% | View Analysis → |
| CRGT | Cortigent, Inc. | SELL | 94% | View Analysis → |
| CPMV | Mosaic ImmunoEngineering Inc. | STRONG SELL | 94% | View Analysis → |
| CODX | Co-Diagnostics, Inc. | STRONG SELL | 94% | View Analysis → |
| CNBX | CNBX Pharmaceuticals Inc. | STRONG SELL | 94% | View Analysis → |
| CLNN | Clene Inc. | STRONG SELL | 94% | View Analysis → |
| CEROW | CERO THERAPEUTICS HOLDINGS, INC. | STRONG SELL | 94% | View Analysis → |
| BCAB | BioAtla, Inc. | STRONG SELL | 93% | View Analysis → |
| SHPH | Shuttle Pharmaceuticals Holdings, Inc. | STRONG SELL | 93% | View Analysis → |
| IMTH | AnTix Holdings, Inc. | STRONG SELL | 93% | View Analysis → |
| HCWB | HCW Biologics Inc. | STRONG SELL | 93% | View Analysis → |
| IOBT | IO Biotech, Inc. | STRONG SELL | 93% | View Analysis → |
| INTI | Inhibitor Therapeutics, Inc. | STRONG SELL | 93% | View Analysis → |
| INO | INOVIO PHARMACEUTICALS, INC. | STRONG SELL | 93% | View Analysis → |
| GCTK | Glucotrack, Inc. | STRONG SELL | 93% | View Analysis → |
| FTII | FutureTech II Acquisition Corp. | STRONG SELL | 93% | View Analysis → |
| FOFA | FAMILY OFFICE OF AMERICA, INC. | STRONG SELL | 93% | View Analysis → |
| EXOZ | EXOZYMES INC. | STRONG SELL | 93% | View Analysis → |
| EVFM | Evofem Biosciences, Inc. | STRONG SELL | 93% | View Analysis → |
| ESLAW | Estrella Immunopharma, Inc. | STRONG SELL | 93% | View Analysis → |
| ENZN | ENZON PHARMACEUTICALS, INC. | STRONG SELL | 93% | View Analysis → |
| GH | Guardant Health, Inc. | STRONG SELL | 92% | View Analysis → |
| CRIS | CURIS INC | STRONG SELL | 92% | View Analysis → |
| ZEOX | Zeo ScientifiX, Inc. | STRONG SELL | 92% | View Analysis → |
| XENE | Xenon Pharmaceuticals Inc. | STRONG SELL | 92% | View Analysis → |
| XCUR | EXICURE, INC. | STRONG SELL | 92% | View Analysis → |
| VYNE | VYNE Therapeutics Inc. | STRONG SELL | 92% | View Analysis → |
| VANI | Vivani Medical, Inc. | STRONG SELL | 92% | View Analysis → |
| VACHW | Voyager Acquisition Corp./Cayman Islands | STRONG SELL | 92% | View Analysis → |
| TVRD | Tvardi Therapeutics, Inc. | STRONG SELL | 92% | View Analysis → |
| TLPH | TALPHERA, INC. | STRONG SELL | 92% | View Analysis → |
| SLDB | Solid Biosciences Inc. | STRONG SELL | 92% | View Analysis → |
| SINT | Sintx Technologies, Inc. | STRONG SELL | 92% | View Analysis → |
| POCI | PRECISION OPTICS CORPORATION, INC. | STRONG SELL | 92% | View Analysis → |
| PMHS | Polomar Health Services, Inc. | STRONG SELL | 92% | View Analysis → |
| PHGE | BiomX Inc. | STRONG SELL | 92% | View Analysis → |
| PGEN | PRECIGEN, INC. | STRONG SELL | 92% | View Analysis → |
| ORGS | Orgenesis Inc. | STRONG SELL | 92% | View Analysis → |
| ONMDW | OneMedNet Corp | STRONG SELL | 92% | View Analysis → |
| ODYY | Odyssey Health, Inc. | STRONG SELL | 92% | View Analysis → |
| NWBO | NORTHWEST BIOTHERAPEUTICS INC | STRONG SELL | 92% | View Analysis → |
| IBO | IMPACT BIOMEDICAL INC. | STRONG SELL | 92% | View Analysis → |
| GTHP | GUIDED THERAPEUTICS INC | STRONG SELL | 92% | View Analysis → |
| GPLB | Green Planet Bio Engineering Co. Ltd. | STRONG SELL | 92% | View Analysis → |
| RENXF | Renalytix plc | STRONG SELL | 92% | View Analysis → |
| NVACW | Profusa, Inc. | STRONG SELL | 92% | View Analysis → |
| NUMD | Nu-Med Plus, Inc. | STRONG SELL | 92% | View Analysis → |
| NTHI | NEONC TECHNOLOGIES HOLDINGS, INC. | STRONG SELL | 92% | View Analysis → |
| MDAIW | Spectral AI, Inc. | STRONG SELL | 92% | View Analysis → |
| MBRX | Moleculin Biotech, Inc. | STRONG SELL | 92% | View Analysis → |
| MBOT | Microbot Medical Inc. | STRONG SELL | 92% | View Analysis → |
| MANE | Veradermics, Inc | STRONG SELL | 92% | View Analysis → |
| LYEL | Lyell Immunopharma, Inc. | STRONG SELL | 92% | View Analysis → |
| INKT | MiNK Therapeutics, Inc. | STRONG SELL | 92% | View Analysis → |
| FEMY | FEMASYS INC | STRONG SELL | 92% | View Analysis → |
| ELTX | Elicio Therapeutics, Inc. | STRONG SELL | 92% | View Analysis → |
| EDIT | Editas Medicine, Inc. | STRONG SELL | 92% | View Analysis → |
| DWTX | Dogwood Therapeutics, Inc. | STRONG SELL | 92% | View Analysis → |
| DBVTF | DBV Technologies S.A. | STRONG SELL | 92% | View Analysis → |
| CVKD | Cadrenal Therapeutics, Inc. | STRONG SELL | 92% | View Analysis → |
| CUBT | Curative Biotechnology Inc | SELL | 92% | View Analysis → |
| CMND | Clearmind Medicine Inc. | SELL | 92% | View Analysis → |
| CLDX | Celldex Therapeutics, Inc. | STRONG SELL | 92% | View Analysis → |
| CLDWW | Calidi Biotherapeutics, Inc. | STRONG SELL | 92% | View Analysis → |
| CINGW | Cingulate Inc. | STRONG SELL | 92% | View Analysis → |
| CELZ | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | STRONG SELL | 92% | View Analysis → |
| NBY | NovaBay Pharmaceuticals, Inc. | STRONG SELL | 91% | View Analysis → |
| MGTX | MeiraGTx Holdings plc | STRONG SELL | 91% | View Analysis → |
| INDP | Indaptus Therapeutics, Inc. | STRONG SELL | 91% | View Analysis → |
| EVMN | Evommune, Inc. | STRONG SELL | 91% | View Analysis → |
| DNABW | Ginkgo Bioworks Holdings, Inc. | STRONG SELL | 91% | View Analysis → |
| CVM | CEL SCI CORP | STRONG SELL | 91% | View Analysis → |
| CTOR | CITIUS ONCOLOGY, INC. | STRONG SELL | 91% | View Analysis → |
| CRDF | Cardiff Oncology, Inc. | STRONG SELL | 91% | View Analysis → |
| COCP | Cocrystal Pharma, Inc. | STRONG SELL | 91% | View Analysis → |
| CNSP | CNS Pharmaceuticals, Inc. | STRONG SELL | 91% | View Analysis → |
| PCVX | Vaxcyte, Inc. | STRONG SELL | 90% | View Analysis → |
| QURE | uniQure N.V. | STRONG SELL | 90% | View Analysis → |
| BMEA | Biomea Fusion, Inc. | STRONG SELL | 90% | View Analysis → |
| VSEEW | VSEE HEALTH, INC. | STRONG SELL | 90% | View Analysis → |
| VGLS | VG Life Sciences Inc. | STRONG SELL | 90% | View Analysis → |
| TIVC | Tivic Health Systems, Inc. | STRONG SELL | 90% | View Analysis → |
| SSKN | STRATA Skin Sciences, Inc. | STRONG SELL | 90% | View Analysis → |
| SNGX | SOLIGENIX, INC. | STRONG SELL | 90% | View Analysis → |
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS, INC. | STRONG SELL | 90% | View Analysis → |
| OTLK | Outlook Therapeutics, Inc. | STRONG SELL | 90% | View Analysis → |
| OSTX | OS Therapies Inc | STRONG SELL | 90% | View Analysis → |
| ONCO | Onconetix, Inc. | STRONG SELL | 90% | View Analysis → |
| NDRA | ENDRA Life Sciences Inc. | STRONG SELL | 90% | View Analysis → |
| LIMNW | Liminatus Pharma, Inc. | STRONG SELL | 90% | View Analysis → |
| LGVN | Longeveron Inc. | STRONG SELL | 90% | View Analysis → |
| KPTI | Karyopharm Therapeutics Inc. | STRONG SELL | 90% | View Analysis → |
| JRSS | JRSIS HEALTH CARE Corp | STRONG SELL | 90% | View Analysis → |
| HURA | TuHURA Biosciences, Inc./NV | STRONG SELL | 90% | View Analysis → |
| GOSS | Gossamer Bio, Inc. | STRONG SELL | 90% | View Analysis → |
| RNTX | Rein Therapeutics, Inc. | STRONG SELL | 90% | View Analysis → |
| RGBPP | Regen BioPharma Inc | STRONG SELL | 90% | View Analysis → |
| NUWE | Nuwellis, Inc. | STRONG SELL | 90% | View Analysis → |
| MGX | Metagenomi Therapeutics, Inc. | STRONG SELL | 90% | View Analysis → |
| FOXOW | FOXO TECHNOLOGIES INC. | STRONG SELL | 90% | View Analysis → |
| FNCH | Finch Therapeutics Group, Inc. | STRONG SELL | 90% | View Analysis → |
| FHTX | Foghorn Therapeutics Inc. | STRONG SELL | 90% | View Analysis → |
| FBLG | FibroBiologics, Inc. | STRONG SELL | 90% | View Analysis → |
| ELAB | PMGC Holdings Inc. | STRONG SELL | 90% | View Analysis → |
| DRMAW | Dermata Therapeutics, Inc. | STRONG SELL | 90% | View Analysis → |
| DRIO | DarioHealth Corp. | STRONG SELL | 90% | View Analysis → |
| DARE | Dare Bioscience, Inc. | STRONG SELL | 90% | View Analysis → |
| CYPH | CYPHERPUNK TECHNOLOGIES INC. | SELL | 90% | View Analysis → |
| CV | CapsoVision, Inc | STRONG SELL | 90% | View Analysis → |
| CTXR | Citius Pharmaceuticals, Inc. | STRONG SELL | 90% | View Analysis → |
| CRVO | CervoMed Inc. | STRONG SELL | 90% | View Analysis → |
| CRMD | CorMedix Inc. | BUY | 90% | View Analysis → |
| CRBU | Caribou Biosciences, Inc. | SELL | 90% | View Analysis → |
| CMPS | COMPASS Pathways plc | STRONG SELL | 90% | View Analysis → |
| CDTTW | CDT Equity Inc. | STRONG SELL | 90% | View Analysis → |
| CYH | COMMUNITY HEALTH SYSTEMS INC | SELL | 89% | View Analysis → |
| OCEA | Ocean Biomedical, Inc. | STRONG SELL | 89% | View Analysis → |
| NKTR | NEKTAR THERAPEUTICS | STRONG SELL | 89% | View Analysis → |
| JUNS | JUPITER NEUROSCIENCES, INC. | STRONG SELL | 89% | View Analysis → |
| IMUX | IMMUNIC, INC. | STRONG SELL | 89% | View Analysis → |
| IBRX | ImmunityBio, Inc. | STRONG SELL | 89% | View Analysis → |
| ENTX | Entera Bio Ltd. | SELL | 89% | View Analysis → |
| CNTB | Connect Biopharma Holdings Ltd | SELL | 89% | View Analysis → |
| CLRB | Cellectar Biosciences, Inc. | STRONG SELL | 89% | View Analysis → |
| PRGO | PERRIGO Co plc | STRONG SELL | 88% | View Analysis → |
| MCRB | Seres Therapeutics, Inc. | STRONG SELL | 88% | View Analysis → |
| FTRE | Fortrea Holdings Inc. | STRONG SELL | 88% | View Analysis → |
| EOLS | Evolus, Inc. | SELL | 88% | View Analysis → |
| BDSX | BIODESIX INC | STRONG SELL | 88% | View Analysis → |
| BHC | Bausch Health Companies Inc. | SELL | 88% | View Analysis → |
| ZNTL | Zentalis Pharmaceuticals, Inc. | STRONG SELL | 88% | View Analysis → |
| ZBIO | Zenas BioPharma, Inc. | STRONG SELL | 88% | View Analysis → |
| VTGN | Vistagen Therapeutics, Inc. | STRONG SELL | 88% | View Analysis → |
| VIR | Vir Biotechnology, Inc. | STRONG SELL | 88% | View Analysis → |
| TXMD | TherapeuticsMD, Inc. | STRONG SELL | 88% | View Analysis → |
| TRAW | Traws Pharma, Inc. | STRONG SELL | 88% | View Analysis → |
| TMCI | TREACE MEDICAL CONCEPTS, INC. | STRONG SELL | 88% | View Analysis → |
| TENX | TENAX THERAPEUTICS, INC. | STRONG SELL | 88% | View Analysis → |
| STRO | SUTRO BIOPHARMA, INC. | STRONG SELL | 88% | View Analysis → |
| SPRY | ARS Pharmaceuticals, Inc. | STRONG SELL | 88% | View Analysis → |
| SNTI | Senti Biosciences, Inc. | STRONG SELL | 88% | View Analysis → |
| SLXNW | Silexion Therapeutics Corp | STRONG SELL | 88% | View Analysis → |
| SLS | SELLAS Life Sciences Group, Inc. | SELL | 88% | View Analysis → |
| SGMO | SANGAMO THERAPEUTICS, INC | STRONG SELL | 88% | View Analysis → |
| SCNX | Scienture Holdings, Inc. | STRONG SELL | 88% | View Analysis → |
| RVRC | Revium Rx. | STRONG SELL | 88% | View Analysis → |
| RVMDW | Revolution Medicines, Inc. | STRONG SELL | 88% | View Analysis → |
| QTIWW | QT IMAGING HOLDINGS, INC. | STRONG SELL | 88% | View Analysis → |
| PULM | Pulmatrix, Inc. | STRONG SELL | 88% | View Analysis → |
| PTIXW | Protagenic Therapeutics, Inc.new | STRONG SELL | 88% | View Analysis → |
| PRTA | PROTHENA CORP PUBLIC LTD CO | STRONG SELL | 88% | View Analysis → |
| PMVP | PMV Pharmaceuticals, Inc. | STRONG SELL | 88% | View Analysis → |
| PETVW | PetVivo Holdings, Inc. | STRONG SELL | 88% | View Analysis → |
| OSRHW | OSR Holdings, Inc. | STRONG SELL | 88% | View Analysis → |
| OCGN | Ocugen, Inc. | STRONG SELL | 88% | View Analysis → |
| LUCD | Lucid Diagnostics Inc. | STRONG SELL | 88% | View Analysis → |
| LNSR | LENSAR, Inc. | STRONG SELL | 88% | View Analysis → |
| LNAI | Lunai Bioworks Inc. | STRONG SELL | 88% | View Analysis → |
| KALA | KALA BIO, Inc. | STRONG SELL | 88% | View Analysis → |
| INBX | Inhibrx Biosciences, Inc. | STRONG SELL | 88% | View Analysis → |
| INBS | INTELLIGENT BIO SOLUTIONS INC. | STRONG SELL | 88% | View Analysis → |
| RGNX | REGENXBIO Inc. | STRONG SELL | 88% | View Analysis → |
| RDGL | VIVOS INC | STRONG SELL | 88% | View Analysis → |
| NRXPW | NRX Pharmaceuticals, Inc. | STRONG SELL | 88% | View Analysis → |
| NOTV | Inotiv, Inc. | STRONG SELL | 88% | View Analysis → |
| MODD | Modular Medical, Inc. | STRONG SELL | 88% | View Analysis → |
| MIST | Milestone Pharmaceuticals Inc. | SELL | 88% | View Analysis → |
| MIRA | MIRA PHARMACEUTICALS, INC. | SELL | 88% | View Analysis → |
| MGNX | MACROGENICS INC | SELL | 88% | View Analysis → |
| MBIO | MUSTANG BIO, INC. | SELL | 88% | View Analysis → |
| IXHL | Incannex Healthcare Inc. | SELL | 88% | View Analysis → |
| IVEVF | Inventiva S.A. | SELL | 88% | View Analysis → |
| IRD | Opus Genetics, Inc. | SELL | 88% | View Analysis → |
| INSM | INSMED Inc | SELL | 88% | View Analysis → |
| INMB | Inmune Bio, Inc. | SELL | 88% | View Analysis → |
| GANX | Gain Therapeutics, Inc. | SELL | 88% | View Analysis → |
| FBRX | Forte Biosciences, Inc. | SELL | 88% | View Analysis → |
| FATE | FATE THERAPEUTICS INC | SELL | 88% | View Analysis → |
| EUDAW | EUDA Health Holdings Ltd | STRONG SELL | 88% | View Analysis → |
| ELUT | ELUTIA INC. | SELL | 88% | View Analysis → |
| DERM | Journey Medical Corp | SELL | 88% | View Analysis → |
| DCOY | Decoy Therapeutics Inc. | SELL | 88% | View Analysis → |
| DCGO | DocGo Inc. | SELL | 88% | View Analysis → |
| CRVS | Corvus Pharmaceuticals, Inc. | SELL | 88% | View Analysis → |
| RARE | Ultragenyx Pharmaceutical Inc. | SELL | 87% | View Analysis → |
| CYTK | CYTOKINETICS INC | SELL | 87% | View Analysis → |
| ZVRA | ZEVRA THERAPEUTICS, INC. | SELL | 87% | View Analysis → |
| TPST | Tempest Therapeutics, Inc. | STRONG SELL | 87% | View Analysis → |
| SRZNW | Surrozen, Inc./DE | STRONG SELL | 87% | View Analysis → |
| SGMT | Sagimet Biosciences Inc. | STRONG SELL | 87% | View Analysis → |
| PLX | Protalix BioTherapeutics, Inc. | STRONG SELL | 87% | View Analysis → |
| PCSA | Processa Pharmaceuticals, Inc. | STRONG SELL | 87% | View Analysis → |
| OMER | OMEROS CORP | STRONG SELL | 87% | View Analysis → |
| GUTS | FRACTYL HEALTH, INC. | SELL | 87% | View Analysis → |
| MTNB | Matinas BioPharma Holdings, Inc. | STRONG SELL | 87% | View Analysis → |
| ISCO | International Stem Cell CORP | SELL | 87% | View Analysis → |
| INM | InMed Pharmaceuticals Inc. | SELL | 87% | View Analysis → |
| ERAS | Erasca, Inc. | SELL | 87% | View Analysis → |
| DYAI | DYADIC INTERNATIONAL INC | SELL | 87% | View Analysis → |
| DRTSW | Alpha Tau Medical Ltd. | SELL | 87% | View Analysis → |
| CURX | Curanex Pharmaceuticals Inc | SELL | 87% | View Analysis → |
| CTMX | CytomX Therapeutics, Inc. | STRONG SELL | 87% | View Analysis → |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | SELL | 87% | View Analysis → |
| CLPT | ClearPoint Neuro, Inc. | SELL | 87% | View Analysis → |
| CELC | Celcuity Inc. | SELL | 87% | View Analysis → |
| ECOR | electroCore, Inc. | SELL | 86% | View Analysis → |
| DMAC | DiaMedica Therapeutics Inc. | STRONG SELL | 86% | View Analysis → |
| COGT | Cogent Biosciences, Inc. | SELL | 86% | View Analysis → |
| AHCO | AdaptHealth Corp. | SELL | 86% | View Analysis → |
| ARAY | ACCURAY INC | SELL | 86% | View Analysis → |
| LLY | ELI LILLY & Co | BUY | 86% | View Analysis → |
| DXCM | DEXCOM INC | BUY | 86% | View Analysis → |
| IMNN | Imunon, Inc. | STRONG SELL | 86% | View Analysis → |
| HSTC | HST Global, Inc. | STRONG SELL | 86% | View Analysis → |
| GRST | ETHEMA HEALTH Corp | STRONG SELL | 86% | View Analysis → |
| GOVX | GeoVax Labs, Inc. | STRONG SELL | 86% | View Analysis → |
| RMHI | Retrieve Medical Holdings, Inc. | STRONG SELL | 86% | View Analysis → |
| MHUAF | Meihua International Medical Technologies Co., Ltd. | SELL | 86% | View Analysis → |
| LXEO | Lexeo Therapeutics, Inc. | SELL | 86% | View Analysis → |
| INTS | INTENSITY THERAPEUTICS, INC. | SELL | 86% | View Analysis → |
| ESMC | ESCALON MEDICAL CORP | SELL | 86% | View Analysis → |
| ELDN | Eledon Pharmaceuticals, Inc. | SELL | 86% | View Analysis → |
| DYNTQ | DYNATRONICS CORP | SELL | 86% | View Analysis → |
| CRNX | Crinetics Pharmaceuticals, Inc. | SELL | 86% | View Analysis → |
| CPRX | CATALYST PHARMACEUTICALS, INC. | BUY | 86% | View Analysis → |
| CNTN | Canton Strategic Holdings, Inc. | SELL | 86% | View Analysis → |
| CNTA | Centessa Pharmaceuticals plc | SELL | 86% | View Analysis → |
| CCEL | CRYO CELL INTERNATIONAL INC | STRONG SELL | 86% | View Analysis → |
| AGL | agilon health, inc. | SELL | 85% | View Analysis → |
| VYGR | Voyager Therapeutics, Inc. | STRONG SELL | 85% | View Analysis → |
| PSNL | Personalis, Inc. | STRONG SELL | 85% | View Analysis → |
| GNLX | GENELUX Corp | STRONG SELL | 85% | View Analysis → |
| BBIO | BridgeBio Pharma, Inc. | SELL | 85% | View Analysis → |
| PTGX | Protagonist Therapeutics, Inc | SELL | 85% | View Analysis → |
| ZOMDF | Zomedica Corp. | STRONG SELL | 85% | View Analysis → |
| XFOR | X4 Pharmaceuticals, Inc | STRONG SELL | 85% | View Analysis → |
| XBIT | XBiotech Inc. | STRONG SELL | 85% | View Analysis → |
| XBIO | Xenetic Biosciences, Inc. | STRONG SELL | 85% | View Analysis → |
| VYCO | VYCOR MEDICAL INC | STRONG SELL | 85% | View Analysis → |
| VTVT | vTv Therapeutics Inc. | SELL | 85% | View Analysis → |
| VIVS | VivoSim Labs, INC. | STRONG SELL | 85% | View Analysis → |
| VERU | VERU INC. | SELL | 85% | View Analysis → |
| UFPT | UFP TECHNOLOGIES INC | BUY | 85% | View Analysis → |
| TOVX | Theriva Biologics, Inc. | STRONG SELL | 85% | View Analysis → |
| TNONW | Tenon Medical, Inc. | STRONG SELL | 85% | View Analysis → |
| TNDM | TANDEM DIABETES CARE INC | STRONG SELL | 85% | View Analysis → |
| TLSIW | TriSalus Life Sciences, Inc. | STRONG SELL | 85% | View Analysis → |
| SXTPW | 60 DEGREES PHARMACEUTICALS, INC. | STRONG SELL | 85% | View Analysis → |
| STEX | Streamex Corp. | STRONG SELL | 85% | View Analysis → |
| SSII | SS Innovations International, Inc. | STRONG SELL | 85% | View Analysis → |
| SNNC | Sibannac, Inc. | STRONG SELL | 85% | View Analysis → |
| SMMT | Summit Therapeutics Inc. | STRONG SELL | 85% | View Analysis → |
| SI | SHOULDER INNOVATIONS, INC. | STRONG SELL | 85% | View Analysis → |
| SER | Serina Therapeutics, Inc. | STRONG SELL | 85% | View Analysis → |
| RZLT | Rezolute, Inc. | STRONG SELL | 85% | View Analysis → |
| RCKTW | ROCKET PHARMACEUTICALS, INC. | STRONG SELL | 85% | View Analysis → |
| QNRX | Quoin Pharmaceuticals, Ltd. | STRONG SELL | 85% | View Analysis → |
| PYXS | Pyxis Oncology, Inc. | STRONG SELL | 85% | View Analysis → |
| PTHS | Pelthos Therapeutics Inc. | STRONG SELL | 85% | View Analysis → |
| PROK | PROKIDNEY CORP. | STRONG SELL | 85% | View Analysis → |
| PDSB | PDS Biotechnology Corp | STRONG SELL | 85% | View Analysis → |
| OWPC | One World Products, Inc. | STRONG SELL | 85% | View Analysis → |
| ONCY | ONCOLYTICS BIOTECH INC | STRONG SELL | 85% | View Analysis → |
| NXGLW | NEXGEL, INC. | SELL | 85% | View Analysis → |
| LIPO | LIPELLA PHARMACEUTICALS INC. | STRONG SELL | 85% | View Analysis → |
| NRXS | Neuraxis, INC | STRONG SELL | 85% | View Analysis → |
| MDNAF | Medicenna Therapeutics Corp. | SELL | 85% | View Analysis → |
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | SELL | 85% | View Analysis → |
| FDMT | 4D Molecular Therapeutics, Inc. | SELL | 85% | View Analysis → |
| ENLV | Enlivex Ltd. | SELL | 85% | View Analysis → |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | SELL | 85% | View Analysis → |
| CVRX | CVRx, Inc. | SELL | 85% | View Analysis → |
| CMPX | Compass Therapeutics, Inc. | SELL | 85% | View Analysis → |
| CHRS | Coherus Oncology, Inc. | SELL | 85% | View Analysis → |
| CGEM | Cullinan Therapeutics, Inc. | SELL | 85% | View Analysis → |
| CGTX | COGNITION THERAPEUTICS INC | SELL | 84% | View Analysis → |
| BAX | BAXTER INTERNATIONAL INC | SELL | 84% | View Analysis → |
| LTRN | Lantern Pharma Inc. | STRONG SELL | 84% | View Analysis → |
| LITS | Lite Strategy, Inc. | SELL | 84% | View Analysis → |
| IMDX | Insight Molecular Diagnostics Inc. | STRONG SELL | 84% | View Analysis → |
| HRGN | Harvard Apparatus Regenerative Technology, Inc. | STRONG SELL | 84% | View Analysis → |
| MBX | MBX Biosciences, Inc. | SELL | 84% | View Analysis → |
| MAZE | Maze Therapeutics, Inc. | SELL | 84% | View Analysis → |
| LXRX | LEXICON PHARMACEUTICALS, INC. | SELL | 84% | View Analysis → |
| IRIX | IRIDEX CORP | SELL | 84% | View Analysis → |
| IPHYF | Innate Pharma SA | SELL | 84% | View Analysis → |
| ENGNW | enGene Holdings Inc. | SELL | 84% | View Analysis → |
| ELTP | ELITE PHARMACEUTICALS INC /NV/ | BUY | 84% | View Analysis → |
| EDSA | Edesa Biotech, Inc. | SELL | 84% | View Analysis → |
| ECIA | ENCISION INC | SELL | 84% | View Analysis → |
| DYN | Dyne Therapeutics, Inc. | SELL | 84% | View Analysis → |
| DRUG | BRIGHT MINDS BIOSCIENCES INC. | SELL | 84% | View Analysis → |
| CVSI | CV Sciences, Inc. | STRONG SELL | 84% | View Analysis → |
| CUE | Cue Biopharma, Inc. | SELL | 84% | View Analysis → |
| CTSO | Cytosorbents Corp | SELL | 84% | View Analysis → |
| CTNM | Contineum Therapeutics, Inc. | SELL | 84% | View Analysis → |
| OGEN | ORAGENICS INC | STRONG SELL | 83% | View Analysis → |
| LIXT | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | SELL | 83% | View Analysis → |
| HUMAW | Humacyte, Inc. | STRONG SELL | 83% | View Analysis → |
| HIND | Vyome Holdings, Inc | SELL | 83% | View Analysis → |
| GTBP | GT Biopharma, Inc. | STRONG SELL | 83% | View Analysis → |
| MRKR | Marker Therapeutics, Inc. | SELL | 83% | View Analysis → |
| FZMD | Fuse Medical, Inc. | SELL | 83% | View Analysis → |
| EWTX | Edgewise Therapeutics, Inc. | SELL | 83% | View Analysis → |
| EVAX | Evaxion A/S | SELL | 83% | View Analysis → |
| CGON | CG Oncology, Inc. | SELL | 83% | View Analysis → |
| NSPR | InspireMD, Inc. | STRONG SELL | 82% | View Analysis → |
| QDEL | QuidelOrtho Corp | SELL | 82% | View Analysis → |
| IDXX | IDEXX LABORATORIES INC /DE | STRONG BUY | 82% | View Analysis → |
| DTIL | PRECISION BIOSCIENCES INC | SELL | 82% | View Analysis → |
| ALKS | Alkermes plc. | SELL | 82% | View Analysis → |
| KRYS | Krystal Biotech, Inc. | BUY | 82% | View Analysis → |
| ADUS | Addus HomeCare Corp | BUY | 82% | View Analysis → |
| INDV | Indivior Pharmaceuticals, Inc. | SELL | 82% | View Analysis → |
| ARDX | ARDELYX, INC. | SELL | 82% | View Analysis → |
| UTHR | UNITED THERAPEUTICS Corp | STRONG BUY | 82% | View Analysis → |
| WVE | Wave Life Sciences Ltd. | STRONG SELL | 82% | View Analysis → |
| XGN | EXAGEN INC. | STRONG SELL | 82% | View Analysis → |
| SCYX | SCYNEXIS INC | SELL | 82% | View Analysis → |
| RSMDF | RESMED INC | STRONG BUY | 82% | View Analysis → |
| PLSE | PULSE BIOSCIENCES, INC. | STRONG SELL | 82% | View Analysis → |
| OSUR | ORASURE TECHNOLOGIES INC | SELL | 82% | View Analysis → |
| NXL | Nexalin Technology, Inc. | STRONG SELL | 82% | View Analysis → |
| MTVA | MetaVia Inc. | SELL | 82% | View Analysis → |
| LSTA | LISATA THERAPEUTICS, INC. | STRONG SELL | 82% | View Analysis → |
| JSPRW | Jasper Therapeutics, Inc. | STRONG SELL | 82% | View Analysis → |
| HYPD | HYPERION DEFI, INC. | STRONG SELL | 82% | View Analysis → |
| HOWL | Werewolf Therapeutics, Inc. | STRONG SELL | 82% | View Analysis → |
| GNPX | Genprex, Inc. | STRONG SELL | 82% | View Analysis → |
| RNAZ | Transcode Therapeutics, Inc. | STRONG SELL | 82% | View Analysis → |
| NNVC | NANOVIRICIDES, INC. | SELL | 82% | View Analysis → |
| NMRA | Neumora Therapeutics, Inc. | SELL | 82% | View Analysis → |
| MRVI | MARAVAI LIFESCIENCES HOLDINGS, INC. | SELL | 82% | View Analysis → |
| MNOV | MEDICINOVA INC | SELL | 82% | View Analysis → |
| JANX | Janux Therapeutics, Inc. | SELL | 82% | View Analysis → |
| EPRX | EUPRAXIA PHARMACEUTICALS INC. | SELL | 82% | View Analysis → |
| ELVN | Enliven Therapeutics, Inc. | SELL | 82% | View Analysis → |
| CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | SELL | 82% | View Analysis → |
| ALGS | Aligos Therapeutics, Inc. | SELL | 81% | View Analysis → |
| NBIX | NEUROCRINE BIOSCIENCES INC | BUY | 81% | View Analysis → |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | BUY | 81% | View Analysis → |
| ROIV | Roivant Sciences Ltd. | SELL | 81% | View Analysis → |
| NTLA | Intellia Therapeutics, Inc. | SELL | 81% | View Analysis → |
| EQ | Equillium, Inc. | SELL | 81% | View Analysis → |
| NVAX | NOVAVAX INC | SELL | 80% | View Analysis → |
| ELAN | Elanco Animal Health Inc | SELL | 80% | View Analysis → |
| BCRX | BIOCRYST PHARMACEUTICALS INC | HOLD | 80% | View Analysis → |
| AMRX | Amneal Pharmaceuticals, Inc. | SELL | 80% | View Analysis → |
| OKUR | OnKure Therapeutics, Inc. | SELL | 80% | View Analysis → |
| DVA | DAVITA INC. | SELL | 80% | View Analysis → |
| ATEC | Alphatec Holdings, Inc. | SELL | 80% | View Analysis → |
| ADCT | ADC Therapeutics SA | SELL | 80% | View Analysis → |
| REGN | REGENERON PHARMACEUTICALS, INC. | BUY | 80% | View Analysis → |
| LUNG | Pulmonx Corp | SELL | 80% | View Analysis → |
| FULC | Fulcrum Therapeutics, Inc. | SELL | 80% | View Analysis → |
| TTRX | Turn Therapeutics Inc. | STRONG SELL | 80% | View Analysis → |
| PASG | Passage BIO, Inc. | STRONG SELL | 80% | View Analysis → |
| LPCN | Lipocine Inc. | SELL | 80% | View Analysis → |
| KOD | Kodiak Sciences Inc. | SELL | 80% | View Analysis → |
| IGC | IGC Pharma, Inc. | SELL | 80% | View Analysis → |
| IBIO | iBio, Inc. | STRONG SELL | 80% | View Analysis → |
| GRI | GRI Bio, Inc. | SELL | 80% | View Analysis → |
| MPLT | MapLight Therapeutics, Inc. | SELL | 80% | View Analysis → |
| FBIOP | Fortress Biotech, Inc. | SELL | 80% | View Analysis → |
| ELMD | Electromed, Inc. | BUY | 80% | View Analysis → |
| DAWN | Day One Biopharmaceuticals, Inc. | SELL | 80% | View Analysis → |
| COYA | Coya Therapeutics, Inc. | SELL | 80% | View Analysis → |
| COLL | COLLEGIUM PHARMACEUTICAL, INC | BUY | 80% | View Analysis → |
| CMMB | Chemomab Therapeutics Ltd. | SELL | 80% | View Analysis → |
| BLLN | BillionToOne, Inc. | BUY | 79% | View Analysis → |
| AMGN | AMGEN INC | BUY | 79% | View Analysis → |
| LDDD | Longduoduo Co Ltd | SELL | 79% | View Analysis → |
| KYNB | KYNTRA BIO, INC. | SELL | 79% | View Analysis → |
| GRDX | GridAI Technologies Corp. | SELL | 79% | View Analysis → |
| MLTX | MoonLake Immunotherapeutics | SELL | 79% | View Analysis → |
| FENC | FENNEC PHARMACEUTICALS INC. | SELL | 79% | View Analysis → |
| LFCR | LIFECORE BIOMEDICAL, INC. DE | SELL | 78% | View Analysis → |
| IRWD | IRONWOOD PHARMACEUTICALS INC | SELL | 78% | View Analysis → |
| GERN | GERON CORP | SELL | 78% | View Analysis → |
| BRNS | Barinthus Biotherapeutics plc. | SELL | 78% | View Analysis → |
| AMPH | Amphastar Pharmaceuticals, Inc. | SELL | 78% | View Analysis → |
| VCYT | VERACYTE, INC. | BUY | 78% | View Analysis → |
| STIM | Neuronetics, Inc. | SELL | 78% | View Analysis → |
| SGRY | Surgery Partners, Inc. | SELL | 78% | View Analysis → |
| SDGR | Schrodinger, Inc. | SELL | 78% | View Analysis → |
| PNTG | Pennant Group, Inc. | SELL | 78% | View Analysis → |
| MYGN | MYRIAD GENETICS INC | SELL | 78% | View Analysis → |
| MD | Pediatrix Medical Group, Inc. | SELL | 78% | View Analysis → |
| CYCN | Cyclerion Therapeutics, Inc. | SELL | 78% | View Analysis → |
| PEN | Penumbra Inc | BUY | 78% | View Analysis → |
| IRMD | IRADIMED CORP | BUY | 78% | View Analysis → |
| SEM | SELECT MEDICAL HOLDINGS CORP | SELL | 78% | View Analysis → |
| PCRX | Pacira BioSciences, Inc. | SELL | 78% | View Analysis → |
| MRK | Merck & Co., Inc. | HOLD | 78% | View Analysis → |
| EBS | Emergent BioSolutions Inc. | SELL | 78% | View Analysis → |
| CERS | CERUS CORP | SELL | 78% | View Analysis → |
| MDXG | MIMEDX GROUP, INC. | SELL | 78% | View Analysis → |
| IONS | IONIS PHARMACEUTICALS INC | SELL | 78% | View Analysis → |
| AGIO | AGIOS PHARMACEUTICALS, INC. | SELL | 78% | View Analysis → |
| VOR | Vor Biopharma Inc. | SELL | 78% | View Analysis → |
| UTMD | UTAH MEDICAL PRODUCTS INC | HOLD | 78% | View Analysis → |
| URGN | UroGen Pharma Ltd. | STRONG SELL | 78% | View Analysis → |
| TRDA | Entrada Therapeutics, Inc. | SELL | 78% | View Analysis → |
| TNYA | Tenaya Therapeutics, Inc. | SELL | 78% | View Analysis → |
| TNGX | Tango Therapeutics, Inc. | SELL | 78% | View Analysis → |
| TERN | Terns Pharmaceuticals, Inc. | SELL | 78% | View Analysis → |
| TELA | TELA Bio, Inc. | SELL | 78% | View Analysis → |
| STTK | Shattuck Labs, Inc. | SELL | 78% | View Analysis → |
| SRRK | Scholar Rock Holding Corp | SELL | 78% | View Analysis → |
| SGHT | Sight Sciences, Inc. | SELL | 78% | View Analysis → |
| SBFMW | Sunshine Biopharma Inc. | SELL | 78% | View Analysis → |
| SABSW | SAB Biotherapeutics, Inc. | STRONG SELL | 78% | View Analysis → |
| RAPP | Rapport Therapeutics, Inc. | STRONG SELL | 78% | View Analysis → |
| PVLA | PALVELLA THERAPEUTICS, INC. | HOLD | 78% | View Analysis → |
| PTPI | Petros Pharmaceuticals, Inc. | STRONG SELL | 78% | View Analysis → |
| PRME | Prime Medicine, Inc. | STRONG SELL | 78% | View Analysis → |
| PMCB | PharmaCyte Biotech, Inc. | SELL | 78% | View Analysis → |
| PLYX | Polaryx Therapeutics, Inc. | SELL | 78% | View Analysis → |
| PGNY | Progyny, Inc. | BUY | 78% | View Analysis → |
| OABIW | OmniAb, Inc. | SELL | 78% | View Analysis → |
| NXTC | NextCure, Inc. | SELL | 78% | View Analysis → |
| NEOG | NEOGEN CORP | SELL | 78% | View Analysis → |
| NAMSW | NewAmsterdam Pharma Co N.V. | SELL | 78% | View Analysis → |
| KPHMW | KIORA PHARMACEUTICALS INC | SELL | 78% | View Analysis → |
| IMA | ImageneBio, Inc. | SELL | 78% | View Analysis → |
| GMED | GLOBUS MEDICAL INC | BUY | 78% | View Analysis → |
| GIPL | Global Innovative Platforms Inc. | SELL | 78% | View Analysis → |
| RNAC | Cartesian Therapeutics, Inc. | SELL | 78% | View Analysis → |
| NUVL | Nuvalent, Inc. | SELL | 78% | View Analysis → |
| MREO | Mereo BioPharma Group plc | SELL | 78% | View Analysis → |
| IVVD | Invivyd, Inc. | SELL | 78% | View Analysis → |
| IPSC | Century Therapeutics, Inc. | SELL | 78% | View Analysis → |
| INFU | InfuSystem Holdings, Inc | BUY | 78% | View Analysis → |
| ENTA | ENANTA PHARMACEUTICALS INC | SELL | 78% | View Analysis → |
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | SELL | 78% | View Analysis → |
| CLYM | Climb Bio, Inc. | SELL | 78% | View Analysis → |
| CNTX | Context Therapeutics Inc. | SELL | 77% | View Analysis → |
| LMAT | LEMAITRE VASCULAR INC | BUY | 77% | View Analysis → |
| INSP | Inspire Medical Systems, Inc. | BUY | 77% | View Analysis → |
| CYRX | Cryoport, Inc. | SELL | 77% | View Analysis → |
| BSX | BOSTON SCIENTIFIC CORP | BUY | 77% | View Analysis → |
| UNH | UNITEDHEALTH GROUP INC | HOLD | 77% | View Analysis → |
| LONA | LeonaBio, Inc. | SELL | 77% | View Analysis → |
| RMTI | ROCKWELL MEDICAL, INC. | SELL | 77% | View Analysis → |
| ESPR | Esperion Therapeutics, Inc. | SELL | 77% | View Analysis → |
| MIRM | Mirum Pharmaceuticals, Inc. | HOLD | 76% | View Analysis → |
| IRON | Disc Medicine, Inc. | SELL | 76% | View Analysis → |
| ADMA | ADMA BIOLOGICS, INC. | BUY | 76% | View Analysis → |
| ACAD | ACADIA PHARMACEUTICALS INC | SELL | 76% | View Analysis → |
| HRMY | Harmony Biosciences Holdings, Inc. | BUY | 76% | View Analysis → |
| MASI | MASIMO CORP | BUY | 76% | View Analysis → |
| IART | INTEGRA LIFESCIENCES HOLDINGS CORP | SELL | 76% | View Analysis → |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BUY | 76% | View Analysis → |
| AXSM | Axsome Therapeutics, Inc. | SELL | 76% | View Analysis → |
| MRNA | Moderna, Inc. | SELL | 76% | View Analysis → |
| LH | LABCORP HOLDINGS INC. | BUY | 76% | View Analysis → |
| KIDS | ORTHOPEDIATRICS CORP | SELL | 76% | View Analysis → |
| ITGR | Integer Holdings Corp | SELL | 76% | View Analysis → |
| ANIK | Anika Therapeutics, Inc. | SELL | 76% | View Analysis → |
| CDNA | CareDx, Inc. | SELL | 76% | View Analysis → |
| HCA | HCA Healthcare, Inc. | BUY | 76% | View Analysis → |
| ELV | Elevance Health, Inc. | HOLD | 76% | View Analysis → |
| OMDA | Omada Health, Inc. | BUY | 76% | View Analysis → |
| NERV | Minerva Neurosciences, Inc. | SELL | 76% | View Analysis → |
| NEPH | NEPHROS INC | BUY | 76% | View Analysis → |
| LCTX | Lineage Cell Therapeutics, Inc. | SELL | 76% | View Analysis → |
| KAPA | Kairos Pharma, LTD. | SELL | 76% | View Analysis → |
| IMNM | Immunome Inc. | SELL | 76% | View Analysis → |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | SELL | 76% | View Analysis → |
| NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | SELL | 76% | View Analysis → |
| DCTH | DELCATH SYSTEMS, INC. | BUY | 76% | View Analysis → |
| CSBR | CHAMPIONS ONCOLOGY, INC. | SELL | 76% | View Analysis → |
| CFOR | CapForce Inc. | SELL | 76% | View Analysis → |
| CELG-RI | BRISTOL MYERS SQUIBB CO | BUY | 76% | View Analysis → |
| PRAX | Praxis Precision Medicines, Inc. | SELL | 75% | View Analysis → |
| SRPT | Sarepta Therapeutics, Inc. | SELL | 75% | View Analysis → |
| SOLV | Solventum Corp | SELL | 75% | View Analysis → |
| EXEL | EXELIXIS, INC. | BUY | 75% | View Analysis → |
| EMBC | Embecta Corp. | HOLD | 75% | View Analysis → |
| MMSI | MERIT MEDICAL SYSTEMS INC | BUY | 75% | View Analysis → |
| IRTC | iRhythm Holdings, Inc. | SELL | 75% | View Analysis → |
| EHC | Encompass Health Corp | BUY | 75% | View Analysis → |
| CORT | CORCEPT THERAPEUTICS INC | SELL | 75% | View Analysis → |
| ALHC | Alignment Healthcare, Inc. | BUY | 75% | View Analysis → |
| AMRN | AMARIN CORP PLCUK | SELL | 75% | View Analysis → |
| AXGN | Axogen, Inc. | SELL | 75% | View Analysis → |
| MMM | 3M CO | HOLD | 75% | View Analysis → |
| TECH | BIO-TECHNE Corp | HOLD | 75% | View Analysis → |
| SKIN | Beauty Health Co | SELL | 75% | View Analysis → |
| SIGA | SIGA TECHNOLOGIES INC | HOLD | 75% | View Analysis → |
| RPRX | Royalty Pharma plc | HOLD | 75% | View Analysis → |
| PROF | Profound Medical Corp. | SELL | 75% | View Analysis → |
| PMDI | PSYCHEMEDICS CORP | SELL | 75% | View Analysis → |
| PCYN | PROCYON CORP | SELL | 75% | View Analysis → |
| LRMR | Larimar Therapeutics, Inc. | SELL | 75% | View Analysis → |
| GLSI | Greenwich LifeSciences, Inc. | STRONG SELL | 75% | View Analysis → |
| CPIX | CUMBERLAND PHARMACEUTICALS INC | SELL | 75% | View Analysis → |
| MNKD | MANNKIND CORP | SELL | 74% | View Analysis → |
| INVA | Innoviva, Inc. | BUY | 74% | View Analysis → |
| ARQT | Arcutis Biotherapeutics, Inc. | SELL | 74% | View Analysis → |
| DNLI | Denali Therapeutics Inc. | SELL | 74% | View Analysis → |
| UHS | UNIVERSAL HEALTH SERVICES INC | BUY | 74% | View Analysis → |
| ARDT | Ardent Health, Inc. | SELL | 74% | View Analysis → |
| ADPT | Adaptive Biotechnologies Corp | HOLD | 74% | View Analysis → |
| FLGT | Fulgent Genetics, Inc. | SELL | 74% | View Analysis → |
| OPCH | Option Care Health, Inc. | HOLD | 74% | View Analysis → |
| OPK | OPKO HEALTH, INC. | SELL | 74% | View Analysis → |
| PFG | PRINCIPAL FINANCIAL GROUP INC | SELL | 74% | View Analysis → |
| ABT | ABBOTT LABORATORIES | HOLD | 74% | View Analysis → |
| WST | WEST PHARMACEUTICAL SERVICES INC | BUY | 74% | View Analysis → |
| OVID | Ovid Therapeutics Inc. | SELL | 74% | View Analysis → |
| OBIO | Orchestra BioMed Holdings, Inc. | SELL | 74% | View Analysis → |
| NGNE | Neurogene Inc. | SELL | 74% | View Analysis → |
| LGNZZ | LIGAND PHARMACEUTICALS INC | BUY | 74% | View Analysis → |
| LENZ | LENZ Therapeutics, Inc. | SELL | 74% | View Analysis → |
| KYTX | Kyverna Therapeutics, Inc. | SELL | 74% | View Analysis → |
| RNXT | RenovoRx, Inc. | SELL | 74% | View Analysis → |
| REPL | Replimune Group, Inc. | STRONG SELL | 74% | View Analysis → |
| RDNT | RadNet, Inc. | SELL | 74% | View Analysis → |
| MNPR | Monopar Therapeutics | SELL | 74% | View Analysis → |
| CNMD | CONMED Corp | SELL | 74% | View Analysis → |
| BEAM | Beam Therapeutics Inc. | HOLD | 73% | View Analysis → |
| KYMR | Kymera Therapeutics, Inc. | SELL | 73% | View Analysis → |
| CHE | CHEMED CORP | BUY | 73% | View Analysis → |
| STOK | Stoke Therapeutics, Inc. | BUY | 73% | View Analysis → |
| PDEX | PRO DEX INC | BUY | 73% | View Analysis → |
| KROS | Keros Therapeutics, Inc. | BUY | 73% | View Analysis → |
| GPCR | Structure Therapeutics Inc. | SELL | 73% | View Analysis → |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | SELL | 72% | View Analysis → |
| LNTH | Lantheus Holdings, Inc. | BUY | 72% | View Analysis → |
| DSGN | Design Therapeutics, Inc. | SELL | 72% | View Analysis → |
| CSTL | CASTLE BIOSCIENCES INC | SELL | 72% | View Analysis → |
| NATR | NATURES SUNSHINE PRODUCTS INC | HOLD | 72% | View Analysis → |
| JBIO | Jade Biosciences, Inc. | SELL | 72% | View Analysis → |
| VRDN | Viridian Therapeutics, Inc.\DE | STRONG SELL | 72% | View Analysis → |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | SELL | 72% | View Analysis → |
| CRSP | CRISPR Therapeutics AG | SELL | 72% | View Analysis → |
| NVNO | enVVeno Medical Corp | SELL | 72% | View Analysis → |
| AFL | AFLAC INC | SELL | 72% | View Analysis → |
| NRC | NATIONAL RESEARCH CORP | SELL | 72% | View Analysis → |
| TWST | Twist Bioscience Corp | HOLD | 72% | View Analysis → |
| RXRX | RECURSION PHARMACEUTICALS, INC. | SELL | 72% | View Analysis → |
| RLAY | Relay Therapeutics, Inc. | SELL | 72% | View Analysis → |
| HUM | HUMANA INC | HOLD | 72% | View Analysis → |
| BIIB | BIOGEN INC. | HOLD | 72% | View Analysis → |
| INCY | INCYTE CORP | BUY | 72% | View Analysis → |
| MEDP | Medpace Holdings, Inc. | BUY | 72% | View Analysis → |
| BBNX | Beta Bionics, Inc. | SELL | 72% | View Analysis → |
| ZYME | Zymeworks Inc. | SELL | 72% | View Analysis → |
| ZURA | Zura Bio Ltd | HOLD | 72% | View Analysis → |
| VREOF | Vireo Growth Inc. | SELL | 72% | View Analysis → |
| VASO | VASO Corp | HOLD | 72% | View Analysis → |
| USPH | U S PHYSICAL THERAPY INC /NV | HOLD | 72% | View Analysis → |
| USAQ | QHSLab, Inc. | SELL | 72% | View Analysis → |
| UNMA | Unum Group | SELL | 72% | View Analysis → |
| TYRA | Tyra Biosciences, Inc. | SELL | 72% | View Analysis → |
| TSHA | Taysha Gene Therapies, Inc. | SELL | 72% | View Analysis → |
| TNXP | Tonix Pharmaceuticals Holding Corp. | SELL | 72% | View Analysis → |
| TELO | Telomir Pharmaceuticals, Inc. | SELL | 72% | View Analysis → |
| SYRE | Spyre Therapeutics, Inc. | SELL | 72% | View Analysis → |
| STXS | Stereotaxis, Inc. | SELL | 72% | View Analysis → |
| SRTS | Sensus Healthcare, Inc. | SELL | 72% | View Analysis → |
| SNWV | SANUWAVE Health, Inc. | SELL | 72% | View Analysis → |
| SANA | Sana Biotechnology, Inc. | SELL | 72% | View Analysis → |
| PEPG | PepGen Inc. | SELL | 72% | View Analysis → |
| PBYI | PUMA BIOTECHNOLOGY, INC. | BUY | 72% | View Analysis → |
| ORKA | Oruka Therapeutics, Inc. | SELL | 72% | View Analysis → |
| MXCT | MAXCYTE, INC. | SELL | 72% | View Analysis → |
| LIFD | LFTD PARTNERS INC. | SELL | 72% | View Analysis → |
| LIANY | LianBio | SELL | 72% | View Analysis → |
| HYPR | Hyperfine, Inc. | SELL | 72% | View Analysis → |
| HOTH | Hoth Therapeutics, Inc. | SELL | 72% | View Analysis → |
| GRTX | Galera Therapeutics, Inc. | SELL | 72% | View Analysis → |
| REVBW | REVELATION BIOSCIENCES, INC. | SELL | 72% | View Analysis → |
| NRIX | Nurix Therapeutics, Inc. | SELL | 72% | View Analysis → |
| MDNC | Medinotec Inc. | BUY | 72% | View Analysis → |
| GRAL | GRAIL, Inc. | SELL | 71% | View Analysis → |
| OFIX | Orthofix Medical Inc. | SELL | 71% | View Analysis → |
| ATRC | AtriCure, Inc. | HOLD | 71% | View Analysis → |
| OCUL | OCULAR THERAPEUTIX, INC | SELL | 71% | View Analysis → |
| HAE | HAEMONETICS CORP | BUY | 71% | View Analysis → |
| RLYB | Rallybio Corp | SELL | 71% | View Analysis → |
| RLMD | RELMADA THERAPEUTICS, INC. | STRONG SELL | 71% | View Analysis → |
| NPCE | NeuroPace Inc | SELL | 71% | View Analysis → |
| CNO-PA | CNO Financial Group, Inc. | HOLD | 71% | View Analysis → |
| PODD | INSULET CORP | HOLD | 70% | View Analysis → |
| MLYS | Mineralys Therapeutics, Inc. | SELL | 70% | View Analysis → |
| RGEN | REPLIGEN CORP | BUY | 70% | View Analysis → |
| CARL | CARLSMED, INC. | HOLD | 70% | View Analysis → |
| BVS | Bioventus Inc. | SELL | 70% | View Analysis → |
| BIOA | BioAge Labs, Inc. | HOLD | 70% | View Analysis → |
| TGTX | TG THERAPEUTICS, INC. | SELL | 70% | View Analysis → |
| HSIC | HENRY SCHEIN INC | BUY | 70% | View Analysis → |
| GKOS | GLAUKOS Corp | HOLD | 70% | View Analysis → |
| XTNT | Xtant Medical Holdings, Inc. | BUY | 70% | View Analysis → |
| VSTM | Verastem, Inc. | SELL | 70% | View Analysis → |
| VRCA | Verrica Pharmaceuticals Inc. | SELL | 70% | View Analysis → |
| TALKW | Talkspace, Inc. | BUY | 70% | View Analysis → |
| PRLD | Prelude Therapeutics Inc | SELL | 70% | View Analysis → |
| NKTX | Nkarta, Inc. | SELL | 70% | View Analysis → |
| LEXX | Lexaria Bioscience Corp. | SELL | 70% | View Analysis → |
| LBRX | LB PHARMACEUTICALS INC | SELL | 70% | View Analysis → |
| KZR | Kezar Life Sciences, Inc. | SELL | 70% | View Analysis → |
| ICCC | IMMUCELL CORP /DE/ | BUY | 70% | View Analysis → |
| RFL | Rafael Holdings, Inc. | SELL | 70% | View Analysis → |
| FONR | FONAR CORP | HOLD | 70% | View Analysis → |
| EXAS | EXACT SCIENCES CORP | HOLD | 70% | View Analysis → |
| LIVN | LivaNova PLC | HOLD | 69% | View Analysis → |
| OLMA | Olema Pharmaceuticals, Inc. | SELL | 69% | View Analysis → |
| KURA | Kura Oncology, Inc. | SELL | 69% | View Analysis → |
| IKT | Inhibikase Therapeutics, Inc. | SELL | 69% | View Analysis → |
| HROW | HARROW, INC. | BUY | 69% | View Analysis → |
| GRCE | Grace Therapeutics, Inc. | HOLD | 69% | View Analysis → |
| GLUE | Monte Rosa Therapeutics, Inc. | HOLD | 69% | View Analysis → |
| PAHC | PHIBRO ANIMAL HEALTH CORP | HOLD | 68% | View Analysis → |
| EHAB | Enhabit, Inc. | SELL | 68% | View Analysis → |
| TMDX | TransMedics Group, Inc. | HOLD | 68% | View Analysis → |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | HOLD | 68% | View Analysis → |
| JAZZ | Jazz Pharmaceuticals plc | SELL | 68% | View Analysis → |
| TVTX | Travere Therapeutics, Inc. | HOLD | 68% | View Analysis → |
| NUVB | Nuvation Bio Inc. | HOLD | 68% | View Analysis → |
| TRUP | TRUPANION, INC. | BUY | 68% | View Analysis → |
| THC | TENET HEALTHCARE CORP | HOLD | 68% | View Analysis → |
| CI | Cigna Group | HOLD | 68% | View Analysis → |
| CNC | CENTENE CORP | SELL | 68% | View Analysis → |
| XOMAP | XOMA Royalty Corp | HOLD | 68% | View Analysis → |
| XNCR | Xencor Inc | SELL | 68% | View Analysis → |
| XERS | Xeris Biopharma Holdings, Inc. | SELL | 68% | View Analysis → |
| WGSWW | GeneDx Holdings Corp. | BUY | 68% | View Analysis → |
| TBPH | Theravance Biopharma, Inc. | BUY | 68% | View Analysis → |
| TARA | Protara Therapeutics, Inc. | SELL | 68% | View Analysis → |
| SPRO | Spero Therapeutics, Inc. | BUY | 68% | View Analysis → |
| SNSE | Sensei Biotherapeutics, Inc. | SELL | 68% | View Analysis → |
| SLNO | SOLENO THERAPEUTICS INC | HOLD | 68% | View Analysis → |
| SION | Sionna Therapeutics, Inc. | SELL | 68% | View Analysis → |
| QTTB | Q32 Bio Inc. | HOLD | 68% | View Analysis → |
| PRVA | Privia Health Group, Inc. | HOLD | 68% | View Analysis → |
| PLRX | PLIANT THERAPEUTICS, INC. | STRONG SELL | 68% | View Analysis → |
| PFHO | PACIFIC HEALTH CARE ORGANIZATION INC | HOLD | 68% | View Analysis → |
| PALI | PALISADE BIO, INC. | SELL | 68% | View Analysis → |
| LFST | LifeStance Health Group, Inc. | SELL | 68% | View Analysis → |
| INBP | INTEGRATED BIOPHARMA INC | SELL | 68% | View Analysis → |
| IMRX | Immuneering Corp | SELL | 68% | View Analysis → |
| IMMX | Immix Biopharma, Inc. | SELL | 68% | View Analysis → |
| ICUI | ICU MEDICAL INC/DE | SELL | 68% | View Analysis → |
| NTRA | Natera, Inc. | BUY | 68% | View Analysis → |
| FOLD | AMICUS THERAPEUTICS, INC. | BUY | 68% | View Analysis → |
| APLS | Apellis Pharmaceuticals, Inc. | BUY | 67% | View Analysis → |
| NVCT | Nuvectis Pharma, Inc. | SELL | 67% | View Analysis → |
| SIBN | SI-BONE, Inc. | BUY | 67% | View Analysis → |
| SEPN | Septerna, Inc. | BUY | 67% | View Analysis → |
| ORMP | ORAMED PHARMACEUTICALS INC. | SELL | 67% | View Analysis → |
| KTTAW | Pasithea Therapeutics Corp. | SELL | 67% | View Analysis → |
| INNV | InnovAge Holding Corp. | HOLD | 67% | View Analysis → |
| ETON | Eton Pharmaceuticals, Inc. | BUY | 67% | View Analysis → |
| KRMD | KORU Medical Systems, Inc. | BUY | 66% | View Analysis → |
| INAB | IN8BIO, INC. | SELL | 66% | View Analysis → |
| IMCR | Immunocore Holdings plc | BUY | 66% | View Analysis → |
| RIGL | RIGEL PHARMACEUTICALS INC | HOLD | 66% | View Analysis → |
| ORIC | Oric Pharmaceuticals, Inc. | SELL | 66% | View Analysis → |
| KNSA | Kiniksa Pharmaceuticals International, plc | BUY | 66% | View Analysis → |
| NEUP | Neuphoria Therapeutics Inc. | SELL | 66% | View Analysis → |
| LQDA | Liquidia Corp | SELL | 66% | View Analysis → |
| IMVT | Immunovant, Inc. | SELL | 66% | View Analysis → |
| PTCT | PTC THERAPEUTICS, INC. | HOLD | 65% | View Analysis → |
| RCUS | Arcus Biosciences, Inc. | SELL | 65% | View Analysis → |
| PHAT | Phathom Pharmaceuticals, Inc. | SELL | 65% | View Analysis → |
| XLO | Xilio Therapeutics, Inc. | HOLD | 65% | View Analysis → |
| VCEL | Vericel Corp | HOLD | 65% | View Analysis → |
| UPB | Upstream Bio, Inc. | SELL | 65% | View Analysis → |
| TECX | Tectonic Therapeutic, Inc. | HOLD | 65% | View Analysis → |
| SPRB | SPRUCE BIOSCIENCES, INC. | SELL | 65% | View Analysis → |
| PHIO | Phio Pharmaceuticals Corp. | SELL | 65% | View Analysis → |
| PBH | Prestige Consumer Healthcare Inc. | BUY | 65% | View Analysis → |
| IDXG | INTERPACE BIOSCIENCES, INC. | HOLD | 65% | View Analysis → |
| ICUCW | SeaStar Medical Holding Corp | SELL | 65% | View Analysis → |
| LFVN | Lifevantage Corp | HOLD | 64% | View Analysis → |
| MOH | MOLINA HEALTHCARE, INC. | SELL | 64% | View Analysis → |
| ORGO | Organogenesis Holdings Inc. | HOLD | 64% | View Analysis → |
| KMTS | KESTRA MEDICAL TECHNOLOGIES, LTD. | HOLD | 64% | View Analysis → |
| HCIL | Hongchang International Co., Ltd | SELL | 64% | View Analysis → |
| HALO | HALOZYME THERAPEUTICS, INC. | BUY | 64% | View Analysis → |
| IQV | IQVIA HOLDINGS INC. | BUY | 63% | View Analysis → |
| PRCT | PROCEPT BioRobotics Corp | HOLD | 63% | View Analysis → |
| GYRE | GYRE THERAPEUTICS, INC. | HOLD | 63% | View Analysis → |
| SHC | Sotera Health Co | SELL | 62% | View Analysis → |
| TARS | Tarsus Pharmaceuticals, Inc. | HOLD | 62% | View Analysis → |
| OSCR | Oscar Health, Inc. | HOLD | 61% | View Analysis → |
| NVCR | NovoCure Ltd | HOLD | 61% | View Analysis → |
| PFE | PFIZER INC | HOLD | 60% | View Analysis → |
| TKNO | Alpha Teknova, Inc. | SELL | 60% | View Analysis → |
| KLRS | Kalaris Therapeutics, Inc. | SELL | 60% | View Analysis → |
| HTFL | Heartflow, Inc. | HOLD | 60% | View Analysis → |
| NNNN | Anbio Biotechnology | SELL | 60% | View Analysis → |
| KRRO | Korro Bio, Inc. | SELL | 59% | View Analysis → |
| DGX | QUEST DIAGNOSTICS INC | SELL | 59% | View Analysis → |
| OM | Outset Medical, Inc. | SELL | 58% | View Analysis → |
| VMD | VIEMED HEALTHCARE, INC. | HOLD | 58% | View Analysis → |
| TCMD | TACTILE SYSTEMS TECHNOLOGY INC | HOLD | 58% | View Analysis → |
| MSLE | Satellos Bioscience Inc. | SELL | 58% | View Analysis → |
| HOOK | HOOKIPA Pharma Inc. | SELL | 56% | View Analysis → |
| MDLN | Medline Inc. | SELL | 55% | View Analysis → |
| SRTAW | Strata Critical Medical, Inc. | HOLD | 55% | View Analysis → |
| IDYA | IDEAYA Biosciences, Inc. | HOLD | 54% | View Analysis → |
| KALV | KalVista Pharmaceuticals, Inc. | HOLD | 54% | View Analysis → |
| ETST | Earth Science Tech, Inc. | HOLD | 52% | View Analysis → |
| TRVI | Trevi Therapeutics, Inc. | SELL | 50% | View Analysis → |
| TCRX | TScan Therapeutics, Inc. | SELL | 50% | View Analysis → |
| SNDX | Syndax Pharmaceuticals Inc | HOLD | 48% | View Analysis → |
| VXRT | Vaxart, Inc. | HOLD | 48% | View Analysis → |
| RANI | Rani Therapeutics Holdings, Inc. | SELL | 48% | View Analysis → |
| CGEN | COMPUGEN LTD | HOLD | 47% | View Analysis → |
| GENB | Generate Biomedicines, Inc. | SELL | 46% | View Analysis → |
| VKTX | Viking Therapeutics, Inc. | SELL | 45% | View Analysis → |
| TEVJF | TEVA PHARMACEUTICAL INDUSTRIES LTD | HOLD | 45% | View Analysis → |
| GDTC | CytoMed Therapeutics Ltd | SELL | 44% | View Analysis → |
| EVOTF | Evotec SE | SELL | 44% | View Analysis → |
| CLLS | Cellectis S.A. | SELL | 44% | View Analysis → |
| INMD | InMode Ltd. | HOLD | 42% | View Analysis → |
| FMCQF | Fresenius Medical Care AG | HOLD | 41% | View Analysis → |
| EIKN | Eikon Therapeutics, Inc. | HOLD | 41% | View Analysis → |
| GHRS | GH Research PLC | HOLD | 40% | View Analysis → |
| EDAP | EDAP TMS SA | HOLD | 39% | View Analysis → |
| CRDL | Cardiol Therapeutics Inc. | HOLD | 39% | View Analysis → |
| ZLAB | Zai Lab Ltd | HOLD | 38% | View Analysis → |
| VERA | Vera Therapeutics, Inc. | STRONG SELL | 35% | View Analysis → |
| SYBX | SYNLOGIC, INC. | STRONG SELL | 35% | View Analysis → |
| RLFTF | Relief Therapeutics Holding SA | SELL | 32% | View Analysis → |
| RNA | Atrium Therapeutics, Inc. | SELL | 21% | View Analysis → |
| NRSNW | NeuroSense Therapeutics Ltd. | HOLD | 20% | View Analysis → |
| LMRI | Lumexa Imaging Holdings, Inc. | HOLD | 18% | View Analysis → |
| NSRX | Nasus Pharma Ltd | HOLD | 18% | View Analysis → |
| NONOF | NOVO NORDISK A S | HOLD | 18% | View Analysis → |
| MOLN | MOLECULAR PARTNERS AG | HOLD | 18% | View Analysis → |
| MMED | MiniMed Group, Inc. | SELL | 18% | View Analysis → |
| RDHL | RedHill Biopharma Ltd. | HOLD | 16% | View Analysis → |
| RDY | DR REDDYS LABORATORIES LTD | HOLD | 15% | View Analysis → |
| RDPTF | Radiopharm Theranostics Ltd | HOLD | 14% | View Analysis → |
| PARK | Park Dental Partners, Inc. | HOLD | 5% | View Analysis → |
| MEOBF | MESOBLAST LTD | HOLD | 5% | View Analysis → |
| MDXH | MDxHealth SA | HOLD | 5% | View Analysis → |
Frequently Asked Questions: Healthcare Stocks
What are the best healthcare stocks to buy in 2026?
Based on our dual AI fundamental analysis (Claude and ChatGPT), 77 healthcare stocks have Buy or Strong Buy ratings in 2026. These are ranked by confidence score based on SEC 10-K and 10-Q filing analysis.
Which healthcare stocks have Strong Buy ratings?
Currently, 3 healthcare stocks have a Strong Buy rating from our AI analysis. Strong Buy indicates both Claude and ChatGPT agree on exceptional fundamentals with high confidence scores above 80%.
How does AI analyze healthcare stocks?
Our dual AI system analyzes SEC EDGAR filings including revenue growth, profit margins, ROE, ROA, debt levels, and cash flow. Both Claude (Anthropic) and ChatGPT (OpenAI) independently evaluate each stock, then we combine their ratings for higher accuracy.
What is the AI confidence score?
AI confidence scores range from 0-100% and indicate how strongly the AI models agree on their rating. Higher confidence means clearer signals from SEC filing data. Healthcare stocks with 80%+ confidence have the most reliable ratings.
Should I invest in healthcare stocks in 2026?
Our AI analysis shows 77 Buy ratings vs 661 Sell ratings in the healthcare sector. Individual stock fundamentals vary significantly - review each stock's detailed analysis. This is not investment advice.
How often are healthcare stock ratings updated?
AI ratings are updated whenever companies file new SEC reports (10-K annually, 10-Q quarterly). Most healthcare stocks are re-analyzed within 24-48 hours of new filings being published on SEC EDGAR.
What data sources are used for healthcare stock analysis?
All analysis is based on official SEC EDGAR filings including Form 10-K (annual reports), Form 10-Q (quarterly reports), and other regulatory disclosures. We do not use price data or market sentiment - only fundamental financial data.